Richmond Pharmacology is pleased to announce our attendance at ESC Congress 2025, the European Society of Cardiology’s flagship event, held in Madrid from 29thAugust– 1st September.

Representing Richmond Pharmacology at ESC Congress:

  • Dr Jörg Täubel, Chief Executive Officer

DrTäubel looks forward to connecting with clinicians, researchers, and industryleaders, sharing Richmond’s expertise in:

  • Early-phase cardiovascular and cardiometabolic trials
  • Novel endpoints and digital health integration
  • Risk-stratified study design and cardiac safety
  • Accelerated CV drug development pathways
  • Patient-focused recruitment and retention

If you’re attending ESC 2025 and seeking an expert partner for cardiovascular clinical trials, we welcome meeting requests at: info@richmondpharmacology.com

Learn more: ESC2025 | ESC 2025 Registration | ESC Annual Congress 2025

‍

Learn more
Back to events

Meet the experts

Richmond Pharmacology has a team of experts with extensive knowledge of clinical research trials.

Careers at Richmond

We are on the lookout for people who love what they do, strive for excellence and who want to make a difference.

Our Videos

Learn more about Richmond Pharmacology by viewing some of our videos.

Latest news

How Richmond Pharmacology Supports Sponsors Navigating ICH E6 (R3)

February 5, 2026
The updated ICH E6 (R3) guideline places greater emphasis on proportionality, risk-based oversight...
Read more

Events

Clinical Trials Innovation Programme

10 - 11 February 2026
Richmond Pharmacology is pleased to attend the Clinical Trials Innovation Programme Conference in Nice, France, 10–11 February 2026.
View event
© 2026 Richmond Pharmacology - all rights reserved
Disclaimer
|
Sitemap
|
Privacy Policy
|
Report A Concern
By clicking “Accept”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.
PreferencesRejectAccept